Svetlana Mosteoru

Female power United in Prevention! Listen to the great ideas the presidents of the ESC Associations have shared in an amazing session at #ESCPrev2025 #escprevmotions @EAPCPresident @denisamuraru @PTBuketAkinci @AnastasiaSMihai

Living in 🌳 and 🏞️ environment is associated with lower incidence of heart failure 💔 Learn more about the best living space for your 💓 👉 doi.org/10.1093/eurjpc…

Are high Lipoprotein(a)🩸 and high #BMI associated with greater risk of atherosclerotic cardiovascular disease 🫀 in primary and secondary #prevention? 🤔 Find the answer 👉 doi.org/10.1093/eurjpc…

Elevated Lp(a) contribute to increased levels of low-density lipoprotein cholesterol in 🧒 with 👨‍👩‍👧‍👦 hypercholesterolemia. Explore more in the link 👉 doi.org/10.1093/eurjpc…

Can PCSK9 inhibitors finally close the therapeutic gap for Lp(a)-driven cardiovascular risk? pubmed.ncbi.nlm.nih.gov/41677790 #CardioTwitter #LipoproteinA #PCSK9 #Atherosclerosis #PrecisionMedicine

💊 Bempedoic acid reduced MACE4 risk, with an additional benefit in patients with elevated steatosis scores 👉 doi.org/10.1093/eurjpc…

💪 High intensity interval aerobic excercise (HIIE) has shown superior efficacy over moderate continuous exercise in enhancing endothelial function. A progressive training strategy is recommended to maximise long-term results. Check this meta-analysis👉doi.org/10.1093/eurjpc…

🦠 Giant cell arteritis significantly increases risk of vascular complications 📢 Do we need cardiovascular risk management and inflammation control strategies? Check this new article 👉 doi.org/10.1093/eurjpc…

Young adults with VTE have an elevated risk of CVD compared with persons in an age- and sex-matched comparison cohort - 📢 results from a Danish nationwide cohort 👉doi.org/10.1093/eurjpc…

Are there new biomarkers able to predict new-onset AF? 🫀NT-proBNP and others not yet incorporated into clinical practice, such as Lp(a) and sVCAM-1, could play a role in the diagnosis and preventive management of AF 👉doi.org/10.1093/eurjpc…

🩸🫘Elevated IL-6 predicts greater long-term eGFR decline, worsening albuminuria, and higher CKD risk Check this article 👉doi.org/10.1093/eurjpc…

In this episode of AtheroTalk, we discuss with Prof. Gerald F. Watts, a leading world expert in the field of Familial Hypercholesterolemia (FH) and Cardio-metabolic Medicine, about his professional journey, about national strategies and policies in FH and about how can young professionals achieve a successful career. Prof. Watts shares his insights about the process of adding clinical meaning into research projects, his mentors and overcoming challenges. He also shares ways to address gaps in care, a fresh perspective on cardiometabolic prevention, methods of thinking and ideas that help researchers keep their research relevant. Tune in and don’t miss the powerful motto that Prof. Watts has followed throughout his exceptional career – “discovery comes to the prepared mind”. 🎧 Spotify: eas.to/ATHTalkE27S 🎧 Apple Podcasts: eas.to/ATHTalkE27A 🎧 Youtube: eas.to/ATHTalkE27Y

Icosapent ethyl was associated with fewer hospitalizations and increased the chances of an individual living without hospitalization 🏥 Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT 👉doi.org/10.1093/eurjpc…

Body roundness index (BRI) can predict CV mortality better than BMI ❤️ Higher BRI is independently associated with increased cardiovascular mortality, particularly among middle aged adults and those with normal BMI 👉doi.org/10.1093/eurjpc…

Haptoglobin (HP) & CVD risk in Type 2 diabetes 🧬 Higher baseline HP levels especially with the HP 1-1 phenotype are linked to greater CVD risk. Fenofibrate’s CV benefit, however, is unchanged by HP phenotype or levels. 👉 doi.org/10.1093/eurjpc…

📢Welcome to new AtheroTalk episode 26!🫀 youtu.be/InhhHQl86YQ?si… open.spotify.com/episode/05daPx… Our guest, Prof. Göran K. Hansson, professor at Karolinska Institutet and former Secretary General of the Royal Swedish Academy of Sciences. @society_eas @EASCongress @BNordestgaard

🫀🧠 1 in 6 patients admitted with MI or stroke get a new diabetes diagnosis unchanged for 30 years. 🔍 Detection is higher with OGTT vs HbA1c alone. 💬 Should diabetes screening after MI/stroke be standardized? 👇 What’s the main barrier? #preventivecardiology

Introducing PreventAble: a new section from the #EJPC focused on how we turn science and guidelines into real-world, global cardiovascular prevention 🌍 Because #CVD is not inevitable. It is #PreventAble! #preventivecardiology #CVDprevention #equityinhealth

Join us for this year's first edition of the Journal Club! 📅 Friday 23rd of January 2026 ⌛ 17:00 to 18:00 CET We will be discussing The Link between Age and Menarche& Cardiovascular Risk lnkd.in/dVyDF2-Z together with Professor Martha Gulati and Dr Sanne Peters and our discussants Dr Priyanka Satish and Dr Jana Schellenberg Register now for free: lnkd.in/dffJcuxB @PTBuketAkinci @DrMarthaGulati @EAPCPresident @GalTsaban

Happy New Year to our wonderful EAPC community! 🌟 As we step into 2026, I wish you all a year filled with purpose, health, and success. We have an exciting year ahead, packed with ambitious projects and new challenges in our mission to advance preventive cardiology. Let’s continue working together to protect hearts across Europe and beyond. 🫀✨ #PreventiveCardiology @escardio

🎄 🎅 Check out just released final issue of the #EJPC of 2026 with a focus on environmental risk factors and preventive cardiology! 🎅 🎄 👇 academic.oup.com/eurjpc/issue @EJPCEiC @SilCastelletti @PeroneFrancesco @PTBuketAkinci @ESC_Journals